Clinical Trials in Austria

Active recruiting clinical trials with sites in Austria. Select a condition below to see detailed trial listings.

Total Trials: 101 // Recruiting: 101 // Updated: Daily

Austria currently has 101 clinical trials with at least one registered site in the country, of which 101 are actively recruiting participants. The most studied conditions at Austria sites are Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including Medical University of Vienna, Medical University of Graz, Medical University Innsbruck. By stage, active Austria trials break down as Phase 1 (2), Phase 2 (11), Phase 3 (26), Phase 4 (5). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in Austria

Multiple Myeloma 3 Acute Myeloid Leukemia 2 Acute Lymphoblastic Leukemia 2 Coronary Artery Disease 2 Tricuspid Regurgitation 2 Uveal Melanoma 2 Stroke 2 Atrial Fibrillation 2 Surgery 2 Breast Cancer 2 Lung Cancer 1 NSCLC Stage IV 1 NSCLC, Stage III 1 SCLC, Extensive Stage 1 SCLC, Limited Stage 1 Leukemia 1 Non-Hodgkin's Lymphoma 1 Anastomotic Leak 1 Major Depressive Disorder (MDD) 1 ACUTE LYMPHOBLASTIC LEUKEMIA 1

All Countries → All Trials →

Other Countries in This Region

🇬🇷Greece 🇩🇪Germany 🇫🇷France 🇮🇹Italy 🇪🇸Spain 🇬🇧United Kingdom 🇳🇱Netherlands 🇧🇪Belgium 🇵🇱Poland 🇸🇪Sweden

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology